Navigation Links
Founder of Nestle-Acquired Company Joins Prismic Pharmaceuticals
Date:2/12/2013

SCOTTSDALE, Ariz., February 12, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based pharmaceutical company focused on prescription Medical Foods, today announced that Danilo Casadei Massari , the founder of CM&D Pharma recently acquired by Nestle, has joined Prismic's Management Team and Board of Directors.

Casadei Massari, who has an outstanding reputation as a successful healthcare entrepreneur, becomes President Europe with additional responsibility for worldwide corporate development. He has also been elected to the company's Board of Directors.

Commenting on this significant development, Peter Moriarty , CEO and Chairman of the Board of Directors, stated, "Danilo has been involved in the founding and development of a number of very successful companies in the pharmaceutical and healthcare arenas. His venture prior to Prismic was CM&D Pharma, a European-based company also focused on prescription Medical Foods. CM&D Pharma was the first acquisition made by Nestle Health Science, a company established by Nestle in 2011 to create a new market between Food and Pharmaceuticals."

Danilo Casadei Massari added that "Prismic is developing an extremely interesting portfolio. These are all IP protected, science-based products that are safe and effective, and can be expeditiously brought to market as prescription Medical Foods. One or two of these are also being evaluated as potential NDA candidates based on clinical data we have seen so far. Our focus is on products that can cost-effectively address commonly occurring disorders in the aging "baby boomer" population, and especially those where inflammation is an underlying cause."

In summing-up, Peter Moriarty stated, "This is another major step-forward for Prismic, especially as we have also recently completed our initial round of equity funding which was significantly over-subscribed."

About Prismic Pharmaceuticals, Inc. Prismic Pharmaceuticals, Inc., is a privately held pharmaceutical company focused on the development and marketing of prescription medical foods for the clinical dietary management of the metabolic processes associated with many of the disorders associated with the aging population, particularly where inflammation is involved. The company, founded in 2011, is headquartered in Scottsdale, Arizona, with offices in Boston, USA, and London, England. Contact 480.422.1810 or visit www.PrismicPharma.com 

INFORMATION CONTACT Peter Moriarty Tel : 480.422.1810


'/>"/>
SOURCE Prismic Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Starkey Hearing Foundation Founders Bill and Tani Austin Honored by Dalai Lama After Recent Hearing Mission to India
2. Key patent awarded to Adjuvance co-founders for pioneering method of producing rare vaccine component.
3. PIMCO founder Bill Gross and wife, Sue, make transformational gift to Cedars-Sinais Advanced Health Sciences Pavilion
4. Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board
5. Vibrant Research Founder Dr. Pratheev Sreetharan Recipient of the TR35 Award from Technology Review Magazine
6. Organovo Announces Two Issued Patents, First Company Patent and Key Founder Patent
7. Microsofts Surface Pro Tablet Makes its Debut and Sells Out Fast; the Company was One of the Few to Defy the Dows Loss Yesterday
8. Perrigo Company Acquires U.K.-based Rosemont Pharmaceuticals Ltd. For Approximately £180 Million Or $283 Million
9. Hemp, Inc.s CEO, Bruce Perlowin, to Speak at Hempcon 2013 Tour on "Hemp and Medical Marijuana Public Company Stocks" and the "Industrial Hemp Industry"
10. Immunotech Laboratories Appoints New Chief Financial Advisor to Strengthen Companys Growth and International Expansion Plan
11. Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... 27, 2016 Kitov ... focused on late-stage drug development, today announced the ... of pivotal batches required for registration of KIT-302 ... This follows Kitov,s announcement in December ... met its primary efficacy endpoint. "We ...
(Date:5/26/2016)... TARE (Transarterial Radio-embolization) Using ... and Overall Decreased Use of Hospital Resource ... specialist healthcare company, has today announced the publication ... of ISPOR (International Society for Pharmacoeconomics and Outcomes ... using yttrium-90 glass microspheres is associated with cost ...
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient ... bei Brustkrebs   QIAGEN N.V. (NASDAQ: ... gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit ... Assays für die Onkologie eingegangen zu sein. Ein ...
Breaking Medicine Technology:
(Date:5/30/2016)... California (PRWEB) , ... May 30, 2016 , ... ... easy to use inside of FCPX," said Christina Austin - CEO of Pixel ... exclusively for use within Final Cut Pro X. Choose from abstract transitions to ...
(Date:5/29/2016)... , ... May 29, 2016 , ... Whole Health Supply ... their new KlipPro KP-240L clipper is available to the public. This is an unusual ... substantially wider than the average clipper. , Everything about this product is concentrated on ...
(Date:5/28/2016)... Hartford, CT (PRWEB) , ... May 28, 2016 , ... After a year and a ... report it was an extraordinary event. The Multiple Pathways of Recovery Conference was held ... from across the country and the United Kingdom came together to explore the many pathways ...
(Date:5/27/2016)... ... 27, 2016 , ... W.S. Badger Co. Inc ., the maker of ... recognized as one of the best small businesses for new dads by Fatherly, the ... small businesses providing progressive benefits to new parents on the organization’s 2016 Best ...
(Date:5/27/2016)... ... May 27, 2016 , ... In response to meager public ... unaware of the plight of aphasia. In collaboration with the American Aphasia Association, ... , The link between stroke and aphasia is relatively unknown, but through collaboration ...
Breaking Medicine News(10 mins):